SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003367
Filing Date
2022-03-10
Accepted
2022-03-10 16:16:19
Documents
14
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K harp-20220310.htm   iXBRL 8-K 57831
2 EX-99.1 harp-ex99_1.htm EX-99.1 217371
3 GRAPHIC img80376846_0.jpg GRAPHIC 3981
  Complete submission text file 0000950170-22-003367.txt   415543

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20220310_lab.xml EX-101.LAB 13996
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20220310.xsd EX-101.SCH 2493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20220310_pre.xml EX-101.PRE 11469
8 EXTRACTED XBRL INSTANCE DOCUMENT harp-20220310_htm.xml XML 4905
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 22729242
SIC: 2836 Biological Products, (No Diagnostic Substances)